Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Global Briefing 2017

Benign prostatic hyperplasia (BPH) treatment devices market comprises of Benign Prostatic Hyperplasia (BPH) treatment devices that are used in the treatment of benign prostatic hyperplasia or benign prostatic hypertrophy, a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. These devices include prostatic stents and catheter ablation devices.

The global benign prostatic hyperplasia (BPH) treatment devices market was estimated to be around $1.6 billion as of 2016. The global benign prostatic hyperplasia (BPH) treatment devices made up around 10% of the overall nephrology and urology devices market in 2016. The benign prostatic hyperplasia (BPH) treatment devices market was the fourth largest market in the global nephrology and urology devices market in 2016.

Development of Minimally Invasive Treatments
Minimally-invasive surgery refers to nephrology and urology surgical techniques that limit the size of incisions needed thereby decreasing wound healing time, pain and risk of infection. Interventional instruments are directed through the body using catheters instead of making large incisions needed in traditional surgery. NeoTract Inc. developed the UroLift System treatment to treat benign prostatic hyperplasia in men. The procedure involves lifting and holding the enlarged prostate tissue to remove blockage to the urethra. In comparison to traditional surgical techniques, this involves no cutting, heating or removal of prostate tissue . New treatment is also developed for enlarged prostate which involves prostate artery embolization by inserting a catheter into the femoral artery in the thigh. This minimally invasive treatment offers men with an enlarged prostate an effective treatment that results in fewer side effects, reduced risk of urinary incontinence and bleeding compared to other BPH therapies whilst also offering a better quality of life.
Nephrology and urology device companies should invest in the development of minimally-invasive techniques to give patients a better quality of life. This would greatly help in capturing the high growth in this division.

Table Of Contents

1. Introduction
2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Characteristics
3. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Historic Growth
‧ Drivers Of The Market
‧ Restraints On The Market
4. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast Growth
‧ Drivers Of The Market
‧ Restraints On The Market
5. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Geography Split
6. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Region
7. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Country
8. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segmentation
9. Benign Prostatic Hyperplasia (BPH) Treatment Devices Competitive Landscape
Endo Health Solutions
Karl Storz
Lumenis
Olympus
Urologix
10. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia (BPH) Treatment Devices Market
11. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, Split By Region, 2016, $ Billion
Table 4: Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Region
Table 5: Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Country
Table 6: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, Split By Region, 2016, $ Billion
Figure 4: Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Region
Figure 5: Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2020, By Country
Figure 6: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, Split By Segments, 2016, $ Billion